Task: Answer the multiple-choice question.
Question: Which drug exhibits a 8.263% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. CCCC(=O)N(Cc1cc2cc(C)ccc2[nH]c1=O)c1ccccc1OC
b. Cc1cc(/C=C2/NC(=S)NC2=O)c(C)n1-c1cccnc1
c. O=c1cc(-c2ccncc2)oc2c1ccc1ccccc12
d. O=c1cc(CN2CCN(c3ccccn3)CC2)nc2sccn12
Answer: b. Cc1cc(/C=C2/NC(=S)NC2=O)c(C)n1-c1cccnc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(/C=C2/NC(=S)NC2=O)c(C)n1-c1cccnc1
Cc1cc(/C=C2/NC(=S)NC2=O)c(C)n1-c1cccnc1
(5E)-5-[(2,5-dimethyl-1-pyridin-3-ylpyrrol-3-yl)methylidene]-2-sulfanylideneimidazolidin-4-one